ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
Highly Potent Fluorogenic Ligands for Triplex DNA: 5-Substituted 2-(Naphthalen-2-yl)-4H-Chromen-4-Ones.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We previously reported two series of 5-substituted flavonoids that selectively bind to triplex DNA while interacting minimally with duplex DNA. Our studies suggest that flavonoids are a promising scaffold for designing triplex ligands, owing to their mild synthesis conditions and ease of structural modification. In the present work, we introduce a novel class of highly potent triplex-specific ligands [5-substituted 2-(naphthalen-2-yl)-4H-chromen-4-ones], developed by expanding the aromatic surface of the flavone moiety. UV thermal denaturation studies indicate these compounds strongly stabilize triplex DNAs, enabling their direct dissociation into random coils without transitioning through a duplex intermediate. Circular dichroism (CD) analysis reveals that these ligands induce much greater conformational changes in triplex DNA compared to duplex DNA. Fluorescent intercalator (FID) displacement assays cross-verify the importance of pendant chains for triplex binding. Viscosity measurements suggest that these compounds bind to triplex DNA via intercalation. Notably, a representative compound (3b) emits strong blue fluorescence upon binding to triplex DNA, allowing direct visualization under UV illumination and providing a convenient method for probing triplex DNA. Electrophoretic mobility shift assay confirms that 3b promotes triplex formation at submicromolar concentrations. Additionally, a plasmid-based assay developed in our lab demonstrates that 3b inhibits DraI endonuclease activity at low micromolar concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.